Matches in Wikidata for { <http://www.wikidata.org/entity/Q66072376> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q66072376 description "assaig clínic" @default.
- Q66072376 description "clinical trial" @default.
- Q66072376 description "clinical trial" @default.
- Q66072376 description "clinical trial" @default.
- Q66072376 description "clinical trial" @default.
- Q66072376 description "ensaio clínico" @default.
- Q66072376 description "ensayo clínico" @default.
- Q66072376 description "ensayu clínicu" @default.
- Q66072376 description "essai clinique" @default.
- Q66072376 description "klinisch onderzoek" @default.
- Q66072376 description "клінічне випробування" @default.
- Q66072376 name "IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT), Patient Reported Outcomes and Safety in Men With Premature Ejaculation (PE)" @default.
- Q66072376 name "IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT), Patient Reported Outcomes and Safety in Men With Premature Ejaculation (PE)" @default.
- Q66072376 type Item @default.
- Q66072376 label "IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT), Patient Reported Outcomes and Safety in Men With Premature Ejaculation (PE)" @default.
- Q66072376 label "IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT), Patient Reported Outcomes and Safety in Men With Premature Ejaculation (PE)" @default.
- Q66072376 prefLabel "IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT), Patient Reported Outcomes and Safety in Men With Premature Ejaculation (PE)" @default.
- Q66072376 prefLabel "IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT), Patient Reported Outcomes and Safety in Men With Premature Ejaculation (PE)" @default.
- Q66072376 P1050 Q66072376-64DD0FBE-24EE-47C4-9226-7B6B8B83B54D @default.
- Q66072376 P1132 Q66072376-CCF5F3B9-A7D1-4F83-AD37-DA67FCEB3DF3 @default.
- Q66072376 P1476 Q66072376-1801A708-2B26-4E71-BAE3-03B46680106C @default.
- Q66072376 P17 Q66072376-4235C109-DB54-452B-A760-A2FD4C5AFE89 @default.
- Q66072376 P2899 Q66072376-68B3E290-2B29-4704-8D34-A601D3E6B4BC @default.
- Q66072376 P3098 Q66072376-527276AC-D23C-4BF6-8F50-11AD889BB9A9 @default.
- Q66072376 P31 Q66072376-8A83266D-F4A0-4361-904A-0B05B531F401 @default.
- Q66072376 P4135 Q66072376-9CC38AD0-BD05-421D-9D08-9B3DC3195440 @default.
- Q66072376 P580 Q66072376-182EBBB6-BB7E-42AA-97C2-B40DA27994C5 @default.
- Q66072376 P582 Q66072376-2EE6468E-4A6E-48B4-856B-C3C8AF318A89 @default.
- Q66072376 P6099 Q66072376-23DAF491-56B4-4699-87DB-94985CE31317 @default.
- Q66072376 P6153 Q66072376-4884EC6D-8CBB-43A8-AE82-26226B026AC4 @default.
- Q66072376 P6153 Q66072376-D7BDC20E-1BC5-4ABF-947B-97890C90848A @default.
- Q66072376 P8363 Q66072376-9D139B36-F913-48E0-B5E4-3C24B87E3DD3 @default.
- Q66072376 P1050 Q319312 @default.
- Q66072376 P1132 "+239" @default.
- Q66072376 P1476 "A Phase 2b, 8-Week, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effects of 3 Different Dose Levels of IX-01 on Intravaginal Ejaculatory Latency Time (IELT), Patient-Reported Outcomes, and Safety in Men With Lifelong Premature Ejaculation (PE)" @default.
- Q66072376 P17 Q30 @default.
- Q66072376 P2899 "+18" @default.
- Q66072376 P3098 "NCT03055806" @default.
- Q66072376 P31 Q30612 @default.
- Q66072376 P4135 "+60" @default.
- Q66072376 P580 "2017-02-28T00:00:00Z" @default.
- Q66072376 P582 "2017-11-17T00:00:00Z" @default.
- Q66072376 P6099 Q42824440 @default.
- Q66072376 P6153 Q30269443 @default.
- Q66072376 P6153 Q30270066 @default.
- Q66072376 P8363 Q78089383 @default.